Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$98.35M
↑ 188% above average
Average (9y)
$-111.53M
Historical baseline
Range
High:$98.35M
Low:$-561.51M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | $98.35M | +117.5% |
| 2024 | $-561.51M | -219.6% |
| 2023 | $-175.67M | -8.2% |
| 2022 | $-162.29M | -22.4% |
| 2021 | $-132.58M | -52.0% |
| 2020 | $-87.22M | -232.9% |
| 2019 | $65.63M | +228.1% |
| 2018 | $-51.24M | -58.6% |
| 2017 | $-32.31M | +57.7% |
| 2016 | $-76.43M | - |